Association Between Dopamine and Cerebral Autoregulation in Preterm Neonates
Overview
Authors
Affiliations
Background: To test the hypothesis that dopamine is associated with impaired cerebral autoregulation (ICA) in a dose-dependent fashion.
Methods: Non a priori designed secondary analysis of a prospectively enrolled cohort study subjects <12 h of life between 24 and 29 weeks gestation. Cerebral saturations (rScO2) and mean arterial blood pressure (MAP) were continuously monitored every 30 s for 96 h. ICA was defined by a 10 min epoch rScO2-MAP correlation coefficient of >0.5.
Results: Twenty-three of 61 subjects (38%) required dopamine. Time spent with ICA was 23% in dopamine-exposed subjects vs. 14% in those not exposed (p = 0.0001). On the epoch level, time spent with ICA was 15%, 29%, 34%, 37%, and 23% in epochs with dopamine titration of 0, 1-5, 6-10, 11-15, and 16-20 μg/kg/min, respectively. Using mixed-effect modeling, ICA for each dopamine titration was significantly higher than unexposed times when controlling for gestation, presence of a patent ductus arteriosus, day of life, MAP less than gestational age, and illness severity score (p < 0.02).
Conclusions: Dopamine exposure during the first 96 h was associated with ICA. Time periods with ICA increased with dopamine exposure in a dose-dependent fashion peaking at a concentration of 11-15 μg/kg/min.
Pellicer A, de Boode W, Dempsey E, Greisen G, Mintzer J, Naulaers G Pediatr Res. 2024; .
PMID: 39511438 DOI: 10.1038/s41390-024-03649-8.
Cerebral autoregulation in pediatric and neonatal intensive care: A scoping review.
Fedriga M, Martini S, Iodice F, Sortica da Costa C, Pezzato S, Moscatelli A J Cereb Blood Flow Metab. 2024; 44(11):1208-1226.
PMID: 38867574 PMC: 11542144. DOI: 10.1177/0271678X241261944.
Terroba-Seara S, Oulego-Erroz I, Palanca-Arias D, Galve-Pradel Z, Delgado-Nicolas S, Perez-Perez A J Perinatol. 2024; 44(10):1496-1503.
PMID: 38664495 DOI: 10.1038/s41372-024-01968-6.
Near-infrared spectroscopy monitoring of neonatal cerebrovascular reactivity: where are we now?.
Martini S, Thewissen L, Austin T, Sortica da Costa C, de Boode W, Dempsey E Pediatr Res. 2023; 96(4):884-895.
PMID: 36997690 DOI: 10.1038/s41390-023-02574-6.
Nissimov S, Joye S, Kharrat A, Zhu F, Ripstein G, Baczynski M Eur J Pediatr. 2022; 182(3):1029-1038.
PMID: 36544000 DOI: 10.1007/s00431-022-04758-4.